Linker Biotech is located in Hangzhou, Zhejiang Province, known as "Paradise", and has set up 6 offices in Shanghai, Beijing, Guangzhou, Nanjing, Suzhou and Xiamen to provide the most convenient and fastest service to users all over the country.
Linker Biologics has signed exclusive or regional distributor agreements with a number of internationally renowned manufacturers to provide a complete range of high-quality products for experts and scholars in China. The main products include: cell biology and flow cytometry products of Invitrogen (USA), flow cytometry products of eBioscience (USA), recombinant cytokines of Peprotech (USA), cytokine ELISA kits of Bender Medsystems (Austria), ELISPOT analyzer of CTL (USA), ELISPOT analyzer of CTL (USA), ELISPOT analyzer of CTL (USA), ELISPOT analyzer of CTL (USA), ELISPOT analyzer of CTL (USA) and ELISPOT analyzer of CTL (USA). ELISPOT analyzer from CTL (USA), ELISPOT test kits from Mabtech (Sweden), fluorescein and various test kits from Enzo (brands: Alexis Biochemicals, Biomol, Apotech) (USA), consumables and cell biology products from Millipore (brands: Chemicon, Upstate, Lincoln, Lincoln, Lincoln, Lincoln, Lincoln, Lincoln, Lincoln, Lincoln, Lincoln, Lincoln, Lincoln) (USA), and cell biology products from Millipore (brands: (brands: Chemicon, Upstate, Linco), and molecular biology kits from Qiagen (Germany). It is worth mentioning that ClusterBio has recently reached a cooperation agreement with Miltenyi Biotec, Germany, to exclusively distribute Miltenyi's immunomagnetic bead sorting products and gentleMACSTM fully automated tissue processor in ten provinces in China starting from September 1, 2009, providing the world's best products for the sorting and enrichment of stem progenitor cells, T-cells and B-cells subpopulations, DC cells, and various types of tumor cells. T and B cell subpopulations, DC cells and various tumor cells. At the same time, our company is always tracking the latest science and technology, paying close attention to foreign scientific research dynamics and the development of emerging companies, and striving to introduce more, better and newer technologies and products for Chinese users.